Amneal Pharmaceuticals, Inc. (AMRX)
$19.57-2.30%Close
BUYBULL · day 18
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $6.2B
- Beta
- 1.22
- P/E (TTM)
- 39.34
- Short % float
- 6.90%
- Days to cover
- 3.1
- SI change
- -0.1%
- 1W
- -3.60%
- 1M
- +13.65%
- vs SPY 1W
- -3.46%
- vs SPY 1M
- +11.14%
Industry peers
FMP comparable companies · ranked by market cap
- TEVABUYTeva Pharmaceutical Industries Limited$47.9BBULLQ 13$41.10+0.19%
- VTRSBUYViatris Inc.$20.5BBULLQ 5$17.64-1.65%
- RDYBUYDr. Reddy's Laboratories Limited$10.4BRECOVERYQ 16$12.48-0.39%
- INDVBUYIndivior Pharmaceuticals Inc$4.5BRECOVERYQ 20$35.83-1.77%
- BHCSELLBausch Health Companies Inc.$2.3BRECOVERYQ 2$6.04-0.67%
- PRGOBUYPerrigo Company plc$2.1BRECOVERYQ 4$15.06-0.52%
- ANIPSELLANI Pharmaceuticals, Inc.$1.7BRECOVERYQ 9$73.89-3.74%
- AMPHBUYAmphastar Pharmaceuticals, Inc.$1.2BRECOVERYQ 9$26.62-2.65%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on AMRX?
- LOPJLB’s latest quantitative signal on Amneal Pharmaceuticals, Inc. (AMRX) is BUY in a BULL regime. Signals are updated daily.
- What market regime is AMRX in?
- Amneal Pharmaceuticals, Inc. (AMRX) is currently classified in the BULL HMM market regime on LOPJLB.
- What does Amneal Pharmaceuticals, Inc. (AMRX) do?
- Amneal Pharmaceuticals, Inc., operating alongside its various subsidiaries, is a diversified pharmaceutical company involved in the development, acquisition of licenses, manufacturing, marketing, and distribution of both generic and specialized medicinal products. These offerings span a multitude of delivery formats and target a wide range of therapeutic needs. Its operations are structured int…